Product category:
Genomics
News Release from: GE Healthcare
Edited by the Laboratorytalk Editorial
Team on 13 February 2004
Agreement covers cell separation media
Two-year collaboration agreement will enable protocols to be developed for the use of media in the separation of a wider range of cell types
Amersham Biosciences announces a two-year collaboration agreement with Cell Therapeutics Scandinavia, to develop fast and simpler methods to isolate specific cell types This will enable Amersham Biosciences to offer superior cell separation methodology than is currently available to cell therapy customers
This article was originally published on Laboratorytalk on 18 Apr 2003 at 8.00am (UK)
Related stories
Tips to improve radiochemical safety
Contains reaction-sized aliquots of radionucleotide in a solution-free format, making experiments easier and safer to do
20,000 human genes in a single experiment
Bioarray can be used to identify up or down regulated genes involved in key biological processes including oncogenesis, metabolism, inflammation and apoptosis
The density gradient centrifugation media from Amersham Biosciences allows researchers to isolate cells according to their density and/or size, and are already established for applications such as lymphocyte isolation, bone marrow processing and blood banking.
Amersham has now secured a two-year collaboration agreement with Cell Therapeutics Scandinavia, which will enable protocols to be developed for the use of RediGrad media, the latest addition to the product portfolio, for the separation of a wider range of cell types.
Guenter Jagschies, vice president protein separations marketing at Amersham Biosciences, comments: "New applications for the RediGrad media will increase Amersham Biosciences's offerings to customers in the cell therapy market, enabling simple and quick separation of a variety of cell types".
Anders Vedin, cairman of Cell Therapeutics Scandinavia, says: "We are extremely satisfied with our collaboration with Amersham Biosciences to leverage our cell based technologies for world wide application helping the chemical, pharmaceutical, biotech and cosmetic industries to better and safer products faster".
• GE Healthcare: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
